Michael Chorny

9PUBLICATIONS
8CO-AUTHORS
Molecular targetsBiomaterialsMedical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 27, 2024
Analysis of the Actions of RARγ Agonists on Growing Osteochondromas in a Mouse Model.

Sonia A Garcia, Kimberly Wilson, Ningfeng Tang

|Feb 24, 2024
Nanocarrier Design for Dual-Targeted Therapy of In-Stent Restenosis.

Ivan S Alferiev, Kehan Zhang, Zoë Folchman-Wagner

|Sep 05, 2022
Robust Chemical Strategy for Stably Labeling Polyester-Based Nanoparticles with BODIPY Fluorophores.

Ivan S Alferiev, Ilia Fishbein, Robert J Levy

|Feb 22, 2022
Poloxamer-linked prodrug of a topoisomerase I inhibitor SN22 shows efficacy in models of high-risk neuroblastoma with primary and acquired chemoresistance.

Ivan S Alferiev, David T Guerrero, Peng Guan

|Feb 15, 2022
Nanocarrier-Based Delivery of SN22 as a Tocopheryl Oxamate Prodrug Achieves Rapid Tumor Regression and Extends Survival in High-Risk Neuroblastoma Models.

Ivan S Alferiev, David T Guerrero, Danielle Soberman

|Sep 28, 2020
Nanomicellar Lenalidomide-Fenretinide Combination Suppresses Tumor Growth in an MYCN Amplified Neuroblastoma Tumor.

Isabella Orienti, Giovanna Farruggia, Ferro Nguyen

Pageof 2